Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.26
(
0.52%
)
Bitcoin
78,135.76
(
-0.02%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 157077

Wednesday, 03/13/2013 3:25:52 PM

Wednesday, March 13, 2013 3:25:52 PM

Post# of 257580
Janet Woodcock will be OGD* acting director following the announced departure of current director, Greg Geba. (Source: FDA Law Blog on Twitter.)

This could conceivably be a positive development for MNTA’s Copaxone ANDA insofar as Woodcock has been a close ally of MNTA dating back to the contaminated-heparin episode in 2008.

*Office of Generic Drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today